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Abstract As an organellar network, mitochondria
dynamically regulate their organization via opposing
fusion and fission pathways to maintain bioenergetic
homeostasis and contribute to key cellular pathways. This
dynamic balance is directly linked to bioenergetic function:
loss of transmembrane potential across the inner membrane
(Dwm) disrupts mitochondrial fission/fusion balance,
causing fragmentation of the network. However, the level
of Dwm required for mitochondrial dynamic balance, as
well as the relative contributions of fission and fusion
pathways, have remained unclear. To explore this, mito-
chondrial morphology and Dwm were examined via
confocal imaging and tetramethyl rhodamine ester (TMRE)
flow cytometry, respectively, in cultured 143B osteosar-
coma cells. When normalized to the TMRE value of
untreated 143B cells as 100%, both genetic (mtDNA-de-
pleted q0) and pharmacological [carbonyl cyanide
m-chlorophenyl hydrazone (CCCP)-treated] cell models
below 34% TMRE fluorescence were unable to maintain
mitochondrial interconnection, correlating with loss of
fusion-active long OPA1 isoforms (L-OPA1). Mechanisti-
cally, this threshold is maintained by mechanistic
coordination of DRP1-mediated fission and OPA1-medi-
ated fusion: cells lacking either DRP1 or the OMA1
metalloprotease were insensitive to loss of Dwm, instead
maintaining an obligately fused morphology. Collectively,
these findings demonstrate a mitochondrial ‘tipping point’
threshold mediated by the interaction of Dwm with both
DRP1 and OMA1; moreover, DRP1 appears to be required
for effective OPA1 maintenance and processing, consistent
with growing evidence for direct interaction of fission and
fusion pathways. These results suggest that Dwm below
threshold coordinately activates both DRP1-mediated fis-
sion and OMA1 cleavage of OPA1, collapsing
mitochondrial dynamic balance, with major implications
for a range of signaling pathways and cellular life/death
events.
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Introduction
Mitochondria have emerged as a highly responsive
organellar network that dynamically balances between two
states: a collection of individual spherical organelles, or an
elaborately interconnected reticular network [1, 2], thus
adapting its organization to directly integrate into crucial
cellular processes including metabolism, apoptosis, autop-
hagy, and proliferation [3]. Moreover, mitochondrial
dynamics are directly linked with bioenergetic function in
an integrated structure/function relationship: loss of trans-
membrane potential (Dwm), which is critical to oxidative
phosphorylation (OxPhos), causes collapse of structural
homeostasis, leading to complete fragmentation of the
mitochondrial network [4]. Despite this, it has remained
unclear what level of bioenergetic function is required for
mitochondrial dynamic balance, as well as the contributing
mechanisms necessary. Here, our results reveal a ‘tipping
point’ threshold of mitochondrial structure/function.
Mitochondrial dynamics employ an elegant balance of
fusion and fission pathways, with each process mediated by
a distinct set of interacting factors. Fusion is carried out by
optic atrophy-1 (OPA1), a dynamin-related GTPase [5] that
mediates fusion of the inner membrane [6, 7], while fusion
of the outer mitochondrial membrane is accomplished by
mitofusins 1 (MFN1) and 2 (MFN2). Fusion of the mito-
chondrial outer and inner membranes allows individual
organelles to exchange components [4] and permits com-
plementation between functional and dysfunctional
organelles [8]. The opposing process, fission, is mediated
by dynamin-related protein-1 (DRP1) [9], which is
recruited to the mitochondrial outer membrane by inter-
acting proteins FIS1 [10, 11] and MFF1 [12] where it forms
an oligomeric ring, dividing mitochondria at discrete sites.
As these processes are carried out by different sets of
interacting factors, inhibition of one pathway causes an
increase in the other: inhibition of DRP1-mediated fission
causes unopposed mitochondrial fusion [13, 14]. In a
unique organellar structure/function relationship, fis-
sion/fusion dynamics are increasingly linked to
mitochondrial bioenergetics via the transmembrane
potential across the inner membrane (Dwm) [15].
Mitochondrial ATP production is accomplished by the
five OxPhos complexes in the mitochondrial inner mem-
brane. Complexes I–IV utilize electron transfer to generate
the proton-motive Dwm that is used by Complex V, the
F1F0 ATP synthase, to create ATP from ADP and Pi. These
complexes are composed of polypeptide subunits encoded
on both chromosomal and mitochondrial DNA (mtDNA).
Strikingly, cells with partial or complete loss of Dwm are
unable to maintain an interconnected, reticular mitochon-
drial morphology: cells depleted of mtDNA (q0 cells), as
well as cells carrying mtDNA mutations affecting Dwm,
show completely fragmented mitochondrial ultrastructure
[16–19], while pharmacological dissipation of Dwm via the
protonophore CCCP and the ionophore valinomycin also
cause fragmentation of the mitochondrial network [4, 20].
While the mitochondria of mtDNA-depleted q0 cells show
a weak ability to fuse and exchange contents via ‘kiss-and-
run’ events [21], both q0 and CCCP-treated cells are unable
to maintain fission/fusion balance, with their mitochondria
existing instead as a fragmented population of organelles
[4, 21]. Despite the importance of Dwm to mitochondrial
structure/function homeostasis, however, it is unclear i)
what level of Dwm is required for maintenance of mito-
chondrial fission/fusion balance, and ii) the relative
contribution of the opposing fusion and fission processes to
Dwm-dependent mitochondrial dynamics in the cell.
Fission/fusion dynamics are integral to mitochondrial
participation in vital cellular processes: fission is
required for stemness [22], mitosis [23, 24], apoptosis
[25], and autophagy [26, 27], while fusion is a necessary
adaptation to nutrient starvation and increased metabolic
demand [3], allowing transmission of Dwm along inter-
connected mitochondria [1]. Moreover, disruption of
mitochondrial dynamics and bioenergetics are emerging
in prevalent diseases such as heart failure and neurode-
generative disorders [28, 29]. As such, the interaction of
Dwm and fission/fusion balance is likely to have major
impact as an underlying mechanism of prevalent human
disease.
In the classical mitochondrial genetic threshold effect,
cells can withstand a high mtDNA mutation load (often up
to 80–90% mutant mtDNA) and maintain full OxPhos
function, but when the overall proportion of mutant
mtDNA exceeds a critical threshold, mitochondrial bioen-
ergetic function collapses, leading to a variety of systemic
and tissue-specific pathologies [30, 31]. Previously, we
showed that heteroplasmic cells (carrying both WT and
mutant mtDNAs) above 80% mutation load have com-
pletely fragmented mitochondria, while cells below 80%
mutation load have effective fission/fusion balance [17],
suggesting that a functional threshold of Dwm is required to
maintain effective fission/fusion balance. Intriguingly, the
OPA1 fusion factor undergoes cleavage and inactivation by
the OMA1 metalloprotease in response to dissipation of
Dwm, causing mitochondrial fragmentation [32–34]; how-
ever, the level of Dwm required and the necessity of
coordinating OPA1 cleavage with other fission/fusion
factors in balancing mitochondrial dynamics and function
remains unclear.
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To explore this, we employed genetic and pharmaco-
logical models of decreased Dwm to determine the
functional and mechanistic requirements for effective
mitochondrial fission/fusion dynamic balance in human
cells. Cultured cells grown in high-glucose media obtain
ATP primarily via glycolysis, allowing the growth and
study of cells with genetic or pharmacological defects in
bioenergetics [35]. Using TMRE flow cytometry to moni-
tor Dwm, our data indicate that cells below 34% of
untreated wild-type (WT) TMRE values cannot maintain
mitochondrial dynamic balance, with concomitant loss of
fusion-active OPA1: this threshold is mediated by DRP1
and OMA1, reflecting a crucial breakpoint of Dwm as a
determinant of mitochondrial homeostasis, with severe
impacts on cell viability and broad relevance to human
disease.
Results
Cells with low Dwm lack reticular mitochondrial
organization
Previous studies have found that cells with OxPhos defects
have complete fragmentation of the mitochondrial network
[4, 16, 21]. To confirm these findings, we examined both
genetic and pharmacological cell models of Dwm loss in a
143B osteosarcoma cell background. 143B206q0 cells have
been depleted of all mtDNA through treatment with
ethidium bromide (EtBr) [36], resulting in loss of mtDNA-
encoded polypeptides, Dwm, and OxPhos function [16, 19].
The protonophore CCCP allows for complete dissipation of
the proton gradient across the mitochondrial inner mem-
brane, providing a pharmacological method to eliminate
Dwm. To examine mitochondrial morphology in WT, q
0,
and CCCP-treated WT lines, cells were immunolabeled for
the TOM20 protein, which is located in the mitochondrial
outer membrane, providing imaging of the mitochondrial
network in these cells. Mitochondrial localization was
confirmed by colocalization with MitoTracker (not shown).
WT cells visualized by confocal fluorescence microscopy
revealed a balance of both fusion and fission, with highly
interconnected, reticular mitochondria existing in the same
cell with fragmented individual mitochondria. Conversely,
q0 cells displayed fragmented, somewhat swollen, mito-
chondria, while WT cells treated with 10 lM CCCP for 1 h
also showed complete fragmentation of the mitochondrial
network (Fig. 1a). MtDNA content was verified by PCR
from total DNA of indicated cell lines. Amplification of
mtDNA nt7130-8113 revealed a strong band in both WT
and CCCP-treated WT cells, while q0 cells showed no
mtDNA present (Fig. 1b). Western blot analysis showed
that the mtDNA-encoded cytochrome c oxidase II
(MTCO2) protein was present in WT and CCCP-treated
WT cells, but absent in q0 cells, as expected (Fig. 1c).
Consistent with this, immunolabeling microscopy showed
strong MTCO2 signal in WT and CCCP-treated WT cells,
but not in q0 cells (not shown). To determine Dwm, cells
were given media containing the Dwm-dependent dye
tetramethyl rhodamine ester (TMRE) and assayed by flow
cytometry (representative histograms, Fig. 1d). This assay
is a novel adaptation of our previous method [19]. WT cells
show a robust average fluorescence of 4172 ± 172 arbi-
trary units (a.u.), while q0s and CCCP-treated WT cells
maintain significantly lower values of 1197 ± 179 a.u and
385 ± 26 a.u., respectively (Fig. 1e). These values are
consistent with those reported for q0 cells via rhodamine-
based evaluation of Dwm [21]. Collectively, these findings
demonstrate that either genetic or pharmacological
decreases in Dwm cause complete fragmentation of the
mitochondrial network, consistent with previous findings
[4, 16].
Cells below a threshold of 34% TMRE fluorescence cannot
maintain mitochondrial interconnection
Intriguingly, q0 cells maintain a modest, intermediate
TMRE signal, statistically greater than that of WT cells
treated with 10 lM CCCP [1197 ± 179 versus 385 ± 26
a.u., respectively (Fig. 1e)], likely due to reversal of the
F1F0 ATP synthase [37]. Despite this, both have com-
pletely fragmented mitochondrial morphology (Fig. 1a).
This suggests that a minimum level of Dwm, greater than
that seen in either q0 or CCCP-treated WT cells, is required
for reticular mitochondrial organization. To explore this,
WT cells were incubated with a range of concentrations of
CCCP for 1 h, and mitochondrial morphology visualized
by anti-TOM20 immunolabeling, as above (Fig. 2a). At 0,
0.1, and 1 lM CCCP, cells displayed full ability to main-
tain mitochondrial interconnection, as reticular
mitochondria were clearly evident. At 10 lM CCCP,
however, no cells were observed with reticular mitochon-
dria, as all cells had fragmented mitochondria (Fig. 2a),
indicating that mitochondrial fission/fusion balance is lost
between 1 and 10 lM CCCP. To further probe this
hypothesis, cells were treated with CCCP from 2 to 10 lM,
and TMRE flow cytometry was used to assay Dwm as in
Fig. 1e. When normalized to untreated WT cells, CCCP at
increasing concentrations produced stepwise decreases in
TMRE fluorescence, defining a range from untreated
(100%) to 10 lM CCCP-treated (9%). Critically, cells
incubated with 4.75 lM CCCP showed a normalized
TMRE signal of 34 ± 5% relative to untreated cells, while
cells incubated with 5 lM CCCP had TMRE signal of
25 ± 5% and q0 cells 29 ± 4% (Fig. 2b). To explore the
impact of these stepwise decreases in Dwm on
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mitochondrial morphology, cells treated with the indicated
concentrations of CCCP were immunolabeled for TOM20.
For quantitation, individual cells were scored as having
predominantly reticular, fragmented, or intermediate
mitochondrial morphologies, as elsewhere [34, 38–40].
When scoring cell profiles, individual cells with more than
two regions of either reticular or fragmented mitochondrial
organization were scored as intermediate. As expected,
untreated cells showed a high proportion of cells with
predominantly reticular (44 ± 17%) and intermediate
morphologies (51 ± 15%), with a small (4 ± 3%) pro-
portion of cells with predominantly fragmented
mitochondria. On the other hand, cells treated with 10 lM
CCCP showed 100% fragmented morphology (Fig. 2c;
Table 1), demonstrating the spectrum of mitochondrial
morphology and Dwm in 143B cells. Strikingly, cells with
intermediate Dwm levels showed a clear threshold effect: at
0, 2, and 4 lM CCCP,[90% of cells assayed had either
reticular or intermediate morphologies, with less than 15%
of cells having a fragmented morphology at these
WT            0                                        WT+CCCP
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Fig. 1 Mitochondrial morphology and bioenergetics in human 143B
osteosarcoma cells. a Cultured 143B cells visualized by confocal
fluorescence microscopy. WT, mtDNA-depleted q0, and CCCP-
treated (10 lM, 1 h) WT cells were immunolabeled for mitochondrial
TOM20 (green). Nuclei stained with DAPI (blue). Outlined box in
Merge (white) is enlarged in Detail panel. Size bar 2 lm. n = 3
experiments. b Polymerase chain reaction of mtDNA. MtDNA-
specific primers were used to amplify nt7130-8113 of human mtDNA
from 100 ng of total cellular DNA isolated from WT, q0, and CCCP-
treated WT cells. n = 3 experiments. c Anti-MTCO2 Western
blotting of lysates from cultured 143B cell lines. Anti-a-tubulin
provides loading control. d Representative histograms of WT, q0, and
CCCP-treated WT cells incubated with 100 nM TMRE and assayed
via flow cytometry. 50,000 cells assayed for TMRE fluorescence (X-
axis) in each experiment. Y-axis indicates number of cells at
fluorescence values expressed in arbitrary units (a.u.). e Average
TMRE fluorescence of WT, q0, and CCCP-treated WT cells in
arbitrary units (a.u.). Values represent average TMRE fluorescence of
indicated cell lines in n[ 3 experiments ± standard error (SE).
**Statistical significance, p\ 0.01, Tukey’s post hoc test following
one-way ANOVA
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concentrations. Conversely, at 5, 6, 8, and 10 lM, at least
80% of cells had predominantly fragmented mitochondrial
morphology (Fig. 2c; Table 1). A sharp dropoff was
observed between cells treated with 4.75 lM and 5 lM
CCCP: at 4.75 lM CCCP, 70% of cells had either reticular
or intermediate morphology, while cells treated with 5 lM
A
B    D
C   E
WT
CCCP:       0          0.1 M       1 M   10 M
WT


















































Fig. 2 Mitochondrial morphology and Dwm monitored across CCCP
titration. a WT cells incubated with 0, 0.1, 1, or 10 lM CCCP for 1 h
were then fixed and immunolabeled for mitochondrial TOM20
(green), followed by DAPI staining of nuclei (blue). Outlined boxes
(white) enlarged in Detail image. Size bar 2 lm. n = 3 experiments.
b WT cells were incubated with 0, 2, 4, 4.25, 4.5, 4.75, 5, 6, 8, or
10 lM CCCP for 1 h, as well as q0 cells, and incubated with 100 nM
TMRE for 20 min. Average TMRE fluorescence given for each
condition, expressed as % of untreated (0 lM CCCP) ± SE. n C 3
experiments for each condition, 50,000 cells assayed per experiment.
All values analyzed by one-way ANOVA, p\ 0.01. c Quantitation of
mitochondrial morphology across CCCP titration. WT cells were
incubated with CCCP as in b for 1 h and processed for TOM20
immunolabeling, as in a. In three independent experiments, cells were
imaged and scored as having predominantly reticular (black),
predominantly fragmented (white), or intermediate (gray) mitochon-
drial morphology. Average % of cells with indicated morphology
shown across CCCP concentrations indicated. For analysis of
statistical significance, see Table 1. d WT cells incubated in the
presence of 4 or 5 lM CCCP and immunolabeled for TOM20 (green).
Size bar 2 lm. e Cells were incubated in the absence or presence of 5
or 10 lM CCCP for 1 or 4 h and assayed by TMRE as in b. n C 3
experiments for each condition, 50,000 cells assayed per experiment.
All values analyzed by one-way ANOVA, p\ 0.01. NS denotes
p[ 0.05, Tukey’s post hoc test
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CCCP showed 80% fragmented morphology (Fig. 2c;
Table 1). Representative images demonstrate this striking
threshold: at 4 lM CCCP, cells showed extensive regions
of mitochondrial interconnection, while at 5 lM CCCP,
the mitochondrial network was largely fragmented
(Fig. 2d). Similar results were obtained for human HeLa
and murine 3T3 cell lines: at 4 lM CCCP, both cell lines
displayed clear evidence of mitochondrial interconnection
when visualized by anti-TOM20 immunolabeling, while
HeLa and 3T3 cells treated with 5 lM CCCP displayed
near-complete fragmentation (Suppl. Figure 1). Strikingly,
TMRE fluorescence of WT cells treated with 5 lM CCCP
and untreated q0 cells are statistically equivalent
[1023 ± 194 a.u. versus 1197 ± 197, respectively, not
significant (NS) (Fig. 2b)], and both have fragmented
mitochondrial morphology (Figs. 1, 2d). Additional
experiments explored whether longer treatments with
CCCP alter Dwm status: cells incubated with 5 lM CCCP
for 1 versus 4 h showed equivalent TMRE values, as did
cells incubated with 10 lM CCCP (Fig. 2e), indicating that
increasing CCCP treatment beyond 1 h does not cause
further decreases in Dwm. This is consistent with findings
elsewhere that indicate that protonophores such as CCCP
act rapidly to dissipate Dwm [41], while longer incubations
do not produce additional decreases in Dwm [42].
As a Nernstian dye that is taken up by actively respiring
mitochondria, TMRE has been extensively used to assay
Dwm via flow cytometry and quantitative microscopy
[43, 44]. Estimation of Dwm from TMRE or other fluores-
cence methods involves a range of factors, including the
concentration of dye within the mitochondria, the cytosol,
and the extracellular space, as well as the overall mass of
mitochondria within the cell [44]. Moreover, protonophores
such as CCCP impact the potential at both the mitochondria
and the plasma membrane [45]. Gerencser et al. [46] found
that the resting Dwm of cultured mammalian cells in high-
glucose medium is -139 mV, while Springett et al. have
successfully employed the oxidation state of mitochondrial
bc1 heme groups to quantitatively explore Dwm, but note the
lack of additional direct methods to cross-correlate their
measurements [47]. Given these caveats, discussion of Dwm
levels are here restricted to TMRE fluorescence values,
rather than extrapolating these differences to mV. TMRE
values are normalized to untreated WT cells (Fig. 2c) to
reflect the relative change between samples. Assuming this
value as 100%, our results show that 4.75 lM CCCP, 5 lM
CCCP, and q0 cells have relative TMRE levels of 34, 25 and
29%, respectively. These results indicate that both pharma-
cological and genetic loss of Dwm to levels below that of
4.75 lM-treated WT cells cause dramatic loss of reticular
mitochondrial organization, representing a critical threshold
required for mitochondrial fission/fusion balance. As mito-
chondrial dynamics are governed by distinct fission and
fusion pathways, we next explored the involvement of
OPA1, OMA1, and DRP1 in maintaining Dwm-dependent
mitochondrial dynamic balance.
OMA1-mediated OPA1 cleavage is required
for Dwm-sensitive mitochondrial dynamic balance
As the mediator of mitochondrial inner membrane fusion,
OPA1 has emerged as a key Dwm-sensitive factor in
mitochondrial dynamics. OPA1 exists as five isoforms in
human cells (a–e): the a and b long isoforms (L-OPA1)
mediate inner membrane fusion, while the c, d, and e short
isoforms (S-OPA1) are fusion-inactive [48]. Dissipation of
Dwm causes cleavage of fusion-mediating L-OPA1 iso-
forms to inactive S-OPA1 by the OMA1 protease, causing
Table 1 Quantitation of mitochondrial morphology in CCCP-treated cells
CCCP (lM) Reticular Intermediate Fragmented
0 44.4 ± 17 51.3 ± 15 4.3 ± 3
2 39.1 ± 10 58.9 ± 11 1.9 ± 1
4 5.7 ± 3* 83.5 ± 6 14.1 ± 7
4.25 15 ± 6 69 ± 4 16 ± 5
4.5 14.7 ± 2 72.3 ± 1 13 ± 3
4.75 4.7 ± 1 65 ± 3 30.3 ± 3
5 1 ± 1 19.6 ± 4** 79.6 ± 5**
6 0 ± 0 20.5 ± 8 79.5 ± 2
8 0 ± 0 5.6 ± 2 94.4 ± 2
10 0 ± 0 0 ± 0 100 ± 0
Values represent the average percentage of cells with the indicated morphology ± standard error in three independent experiments,[150 cells
scored. Statistical analysis: data analyzed by one-way ANOVA, p\ 0.05. * p\ 0.05, ** p\ 0.01, compared to value immediately above,
Tukey’s post hoc test. These values were used to generate the bar graph of these data corresponding to Fig. 2c
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loss of mitochondrial fusion [32, 33], while expression of
S-OPA1 activates mitochondrial fission [34]. We, there-
fore, next explored OPA1 status in q0 and CCCP-treated
143B models, as in Figs. 1 and 2. Anti-OPA1 Western
blotting revealed that WT cells have prominent bands for
the L-OPA1 a and b isoforms, with the fusion-inactive
S-OPA1 showing a strong band for the d short isoform and
minor bands for the c and e isoforms (Fig. 3a). q0 cells
show dramatically decreased L-OPA1 isoforms, with
increased levels of the c and e S-OPA1 isoforms. CCCP-
treated WT cells show even more pronounced loss of
L-OPA1 isoforms, with a near-complete loss of the a iso-
form and only a faint band for the b isoform, while the
S-OPA1 isoforms are increased, with a major band for the e
short isoform (Fig. 3a). Quantitation of OPA1 isoforms
confirms this: untreated WT cells maintain 43 ± 3%
L-OPA1 of total OPA1 signal, while q0 cells (33 ± 2%
L-OPA1) and 10 lM CCCP-treated WT cells (20 ± 3%),
show significant decreases in the proportion of L-OPA1
relative to untreated WTs. OPA1 blotting at intermediate
CCCP concentrations mirrors the morphological threshold
observed in Fig. 2c, d: WT cells treated with 4.25, 4.5, and
4.75 lM CCCP maintain similar L-OPA1 levels to
untreated WT cells (45 ± 2, 44 ± 5, and 46 ± 4%,
respectively), while WT cells treated with 5 lM CCCP
have a significantly lower proportion of L-OPA1
(33 ± 3%) (Fig. 3b). These results suggest that [40%
L-OPA1 (of total OPA1) is necessary for mitochondrial
fusion capability, and further suggests that the Dwm
threshold observed for mitochondrial interconnection
(Fig. 2) reflects the available pool of fusion-active L-OPA1
isoforms.
As the OMA1 metalloprotease has emerged as a critical
regulator of stress-sensitive OPA1-mediated mitochondrial
fusion, we next examined the role of OMA1 in this process.
While OPA1 is cleaved by a variety of proteases including
YME1 [48–50], AFG3L1, and AFG3L2 [33], only OMA1
has been shown to mediate Dwm-sensitive cleavage of
OPA1 [32, 33], suggesting OMA1 as a likely regulator of
the observed Dwm threshold of mitochondrial fission/fusion
balance. To explore this, experiments examined pharma-
cological and genetic Dwm loss, as above, in mouse
embryonic fibroblasts (MEFs) either carrying (OMA1?/?)
or ablated for (OMA1-/-) the OMA1 gene (kind gift of Dr.
Carlos Lopez-Otin, University of Oviedo). When assayed
via TMRE flow cytometry, OMA?/? cells show an average
fluorescence of 2298 ± 294 a.u. Strikingly, OMA1-/-
cells show a significantly decreased TMRE signal of
1227 ± 132 a.u., relative to OMA1?/? cells (Fig. 3c),
indicating that these cells have a low basal Dwm. Both
OMA1?/? and OMA1-/- cell lines showed massive
decreases in TMRE fluorescence when treated with 20 lM
CCCP, with average fluorescence values of 567 ± 50 and
544 ± 21, respectively (Fig. 3c). Using EtBr treatment per
King and Attardi [36], q0 MEF lines were generated in both
OMA1?/? and OMA1-/- backgrounds. In both cases, the
q0 line had a dramatically decreased Dwm relative to the
control MEFs, as assayed by TMRE flow cytometry:
OMA1?/? q0 cells had average TMRE fluorescence of
925 ± 42 versus 2298 ± 294 a.u. for control OMA1?/?
cells, while OMA1-/- q0 cells had TMRE signal of
503 ± 118 a.u. versus 1227 ± 132 for control OMA1-/-
cells (Fig. 3c). We next examined OPA1 status in OMA1?/
? and OMA1-/- cells in the absence or presence of CCCP.
While untreated OMA1?/? and OMA1-/- cells showed
equivalent levels of L- and S-OPA1 isoforms, CCCP-
treated OMA1?/? cell lysates showed loss of L-OPA1
isoforms and concomitant increase in S-OPA1 isoforms.
Conversely, OMA1-/- cells treated with CCCP showed no
change in OPA1 isoforms versus untreated OMA1-/-
control cell lysates (Fig. 3d).
When examined by anti-TOM20 immunolabeling,
OMA1?/? MEFs show the expected mix of fragmented and
reticular morphologies (Fig. 3d). Conversely, OMA1-/-
cells show extensive interconnection (Fig. 3d), indicating
that cells lacking the OMA1 metalloprotease retain full
mitochondrial fusion capability, despite a low basal Dwm.
When treated with CCCP, OMA1?/? cells show the
expected fragmented morphology, while OMA1-/- cells
retain extensive mitochondrial interconnection in the
presence of CCCP (Fig. 3d), consistent with findings
elsewhere [51, 52]. Similarly, OMA1?/? q0 cells show a
fragmented morphology, consistent with the results in
Figs. 1 and 2, and previous findings [16, 18]. Strikingly,
however, OMA1-/- q0 cells show extensive mitochondrial
interconnection (Fig. 3d), despite the loss of Dwm. Quan-
titation of morphology confirms this: while OMA1?/? cells
show dramatic loss of reticular and intermediate mor-
phologies when treated with CCCP, compared with
untreated OMA?/? cells, OMA1-/- cells do not show a
significant change in the proportion of cells with reticular
or intermediate morphologies when treated with CCCP
(Fig. 3f). These results demonstrate that cells lacking
OMA1 are insensitive to loss of Dwm, retaining a fused
mitochondrial network when challenged with either phar-
macological or genetic loss of Dwm. However, we note that
CCCP-treated OMA1-/- cells show an overall decrease in
the proportion of cells’ reticular mitochondria (21 ± 13
versus 40 ± 3% for untreated OMA1-/- cells) (Fig. 3f).
While this decrease is not statistically significant, it does
suggest that additional factors may be involved.
These findings strongly indicate that L-OPA1 is a key
determinant of the Dwm-dependent mitochondrial fis-
sion/fusion dynamics observed in Fig. 2. To explore this
further, we incubated WT cells with 5 and 10 lMCCCP, as
in Fig. 2, followed by recovery in CCCP-free media, and
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Fig. 3 Role of OPA1 and OMA1 in Dwm-dependent mitochondrial
dynamics. a Anti-OPA1 Western blotting of 143B cells. Lysates were
prepared from WT, q0, and 10 lM CCCP-treated WT cells, followed
by blotting with anti-OPA1 monoclonal antibody. L-OPA1 (a, b) and
S-OPA1 (c–e) isoforms labeled as indicated. n = 3 experiments.
b Quantitation of Western blot densitometry using Image J, ± SE.
n = 3 experiments. *Statistical significance, p\ 0.05, one-way
ANOVA followed by Dunnett’s post hoc test. c TMRE analysis of
OMA1?/? and OMA1-/- mouse embryonic fibroblasts (MEFs). MEFs
with (OMA1?/?) and lacking (OMA1-/-) the murine OMA1 gene
were incubated in the absence or presence of 20 lM CCCP for 1 h, or
in the absence or presence of EtBr for 10 days. Untreated, CCCP-
treated, or q0 MEFs were incubated with 100 nM TMRE and TMRE
fluorescence quantitated via flow cytometry. Average TMRE fluo-
rescence expressed in a.u. ± SE. n C 3 experiments for each
condition, 50,000 cells assayed per experiment. *Statistical
significance, p\ 0.01, one-way ANOVA followed by Dunnett’s post
hoc test. d Anti-OPA1 Western blotting of lysates from OMA1?/
? and -/- MEFs. MEFs were incubated in the absence or presence of
20 lM CCCP for 1 h and lysates were prepared, followed by blotting
to PVDF and blotting with anti-OPA1. n = 3 experiments. e Mito-
chondrial morphology of OMA1?/? and OMA1-/- MEFs. Untreated,
CCCP-treated (20 lM, 1 h), or mtDNA-depleted q0 MEFs in each
background were immunolabeled for mitochondrial TOM20 (green)
and counterstained with DAPI (blue). n = 3 experiments. Size bar
2 lm. f Quantitation of mitochondrial morphology OMA1?/? and
OMA1-/- MEFs in the absence or presence of CCCP. As in Fig. 2c,
cells were imaged and scored as having predominantly reticular
(black), predominantly fragmented (white), or intermediate (gray)
mitochondrial morphology. Average % of cells with indicated
morphology in n = 3 experiments
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examined mitochondrial morphology. Untreated WT cells
maintained the expected balance of mitochondrial fission
and fusion, while cells incubated with 5 and 10 lM CCCP
both showed the extensive mitochondrial fragmentation
noted in Fig. 2 (Fig. 4a).WhenCCCP-treated cells (either 5-
or 10 lM-treated) were allowed to recover in fresh media
lacking CCCP, extensivemitochondrial interconnection was
observed in both, with highly elongated, networked mito-
chondria observed (Fig. 4a). Western blotting of CCCP-
treated cells showed the expected loss of L-OPA1 isoforms,
while CCCP-treated cells allowed to recover in CCCP-free
media failed to restore L-OPA1 (Fig. 4b), consistent with the
results of Griparic et al. [48]. Thus, while the results of Fig. 3
indicate that L-OPA1 levels correlate with the observed
fusion threshold, with OMA1 playing a major role in medi-
ating Dwm-dependent mitochondrial dynamic balance,
Fig. 4 shows that extensive mitochondrial interconnection
can nevertheless be demonstrated in the absence of an
abundant pool of fusion-active L-OPA1. Similarly, CCCP-
treated OMA1-/- cells show a decreased (though not sta-
tistically significant) percentage of cells with reticular
morphology, relative to untreated OMA1-/- cells (Fig. 3f).
Taken together, these findings suggest that other factors
likely play a role in Dwm-dependent mitochondrial dynamic
balance. Notably, DRP1 is actively recruited tomitochondria
of CCCP-treated cells [53], suggesting that CCCP treatment
and recovery cause effective inhibition of DRP1-mediated
fission, causing the observed extensive mitochondrial
interconnection in Fig. 4. We, therefore, next explored the
contribution of DRP1 to Dwm-dependent mitochondrial
dynamic balance.
DRP1 is required for Dwm-dependent mitochondrial
dynamic balance
To further explore the mechanism of Dwm-dependent
mitochondrial dynamics, we next tested the role of DRP1-
mediated fission in this process. Western blotting for DRP1
in WT, q0, and CCCP-treated WT cell lysates revealed no
appreciable differences in DRP1 expression between the
different cell lines (Fig. 5a). To explore the functional role
of DRP1 in Dwm-sensitive fission/fusion balance, we
examined Dwm loss under both pharmacological inhibition
and genetic knockout of DRP1. Mitochondrial morphology
was examined in WT and q0 cells in the presence or
absence of mdivi-1, a small molecular agent that prevents
the oligomerization of DRP1 at the mitochondrial outer
membrane [13]. Untreated WT cells displayed the expected
mixture of fusion and fission, while many mdivi-1-treated
WT cells showed elaborately interconnected mitochondria,
as visualized using MitoTracker (Suppl. Figure 2A).
Quantitation of morphology, as in Fig. 2, reflected this:
36 ± 3% of untreated WT cells had a predominantly
reticular morphology, but mdivi-1 treatment significantly
increased this to 56 ± 6%. Similarly, the proportion of
cells with fragmented mitochondria significantly
decreased, falling from 11 ± 1% in untreated WT cells to
4 ± 2% in response to mdivi-1 (Suppl. Figure 2B). These
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Fig. 4 CCCP treatment and
recovery restores mitochondrial
interconnection. a WT cells
were incubated with either 5 or
10 lM CCCP for 1 h without or
with subsequent recovery in
media lacking CCCP (wash) for
3.5 h [48] followed by anti-
TOM20 immunolabeling, n = 3
experiments. b Western blotting
of WT cells treated as in
a. Lysates were prepared from
untreated WT, 10 lM CCCP-
treated WT cells, and 10 lM
CCCP-treated WT cells allowed
to recover in CCCP-free media,
followed by blotting with anti-
OPA1 and anti-tubulin
monoclonal antibodies. L-OPA1
(a, b) and S-OPA1 (c–
e) isoforms labeled as indicated.
n = 3 experiments
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results demonstrate that mdivi-1 inhibits fission in this
system, causing increased mitochondrial fusion. Untreated
q0 cells show a completely fragmented mitochondrial
ultrastructure, as in Fig. 1. Strikingly, however, mdivi-1-
treated q0 cells also show a completely fragmented mor-
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Fig. 5 Dwm-sensitive mitochondrial dynamics require DRP1. a Anti-
DRP1 Western blotting of lysates from cultured 143B cell lines. Anti-
a-tubulin provides loading control. n = 3 experiments. b Anti-DRP
Western blotting of control and DRP1 knockout HCT116 cells
without or with CCCP treatment (10 lM, 1 h). Anti-a-tubulin
provides loading control. n = 3 experiments. c TMRE flow cytometry
of HCT116 and DRP1 knockout cell lines in the absence or presence
of CCCP (10 lM, 1 h). Average TMRE fluorescence expressed in
a.u. ± SE. n C 3 experiments for each condition, 50,000 cells
assayed per experiment. **Statistical significance from corresponding
untreated cell lines, p\ 0.01, Tukey’s post hoc test following one-
way ANOVA. d Immunofluorescence of HCT116 control and DRP1
knockout cells. Untreated, CCCP-treated (10 lM, 1 h), and mtDNA-
depleted q0 cells in each background were immunolabeled for
TOM20 (green) and stained with DAPI (blue). Outlined boxes (white)
enlarged in Detail image. Size bar 2 lm. n = 3 experiments.
e Quantitation of mitochondrial morphology in HCT116 and DRP1
knockout cells in the absence or presence of CCCP. Cells were
imaged and scored as having predominantly reticular (black),
predominantly fragmented (white), or intermediate (gray) mitochon-
drial morphology, as above (Figs. 2c, 3f). Average % of cells with
indicated morphology in n = 3 experiments
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observed to have a reticular morphology in either the
absence or presence of mdivi-1, (Suppl. Figure 2A, B).
Similar results were obtained in CCCP-treated WT cells:
mdivi-1-treated WT cells challenged with 5 or 10 lM
CCCP also showed total fragmentation of the mitochon-
drial network, with no observable organellar
interconnection (Suppl. Figure 2C), suggesting that Dwm-
dependent fragmentation of the mitochondrial network
might be independent of DRP1-mediated fission.
However, mdivi-1 may not be sufficiently potent to
completely inhibit DRP1 fission activity, particularly if loss
of Dwm stimulates DRP1 functional activity, as found
elsewhere [39] via phosphorylation at residue Ser656 [54].
To more rigorously test the requirement for DRP1 in Dwm-
sensitive mitochondrial dynamics, we examined human
HCT116 cells containing or knocked out for DRP1 (kind
gift of Dr. Richard Youle, NIH) with pharmacological
(CCCP) or genetic (mtDNA-depleted) loss of Dwm. Anti-
DRP1 Western blotting of HCT116 control and DRP1
knockout cells confirmed that DRP1 is present in both
untreated and CCCP-treated HCT116 cells, while DRP1
knockout cells (without or with CCCP treatment) lack
DRP1 (Fig. 5b). TMRE flow cytometry was used as above
to monitor Dwm: HCT116 cells maintained a TMRE signal
of 5368 ± 551 a.u. while CCCP treatment lowered their
TMRE value to 1438 ± 230 a.u. DRP1 knockout cells,
however, had an average TMRE fluorescence of
3379 ± 85 a.u., significantly lower than control HCT116s,
consistent with bioenergetic functional defects in cells with
genetically altered fission or fusion dynamics [55]. CCCP-
treated DRP1 knockout cells showed a dramatic decrease
in TMRE signal to 1092 ± 72 a.u., confirming that CCCP
dissipates Dwm in HCT116 and DRP1KO cells (Fig. 5c).
Mitochondrial morphology of HCT116 and DRP1KO cells
was monitored via confocal microscopy with anti-TOM20
immunolabeling, as above. While control HCT116 cells
maintained a largely intermediate morphology, with
regions of both mitochondrial interconnection and frag-
mentation, DRP1 knockout cells showed elaborately
interconnected mitochondria, as visualized by TOM20
imaging (Fig. 5d). In response to either CCCP treatment or
depletion of mtDNA (via EtBr treatment), control HCT116
cells show fragmentation of the mitochondrial network, as
in Fig. 1. Conversely, DRP1 knockout cells maintain an
extensively interconnected mitochondrial network when
treated with CCCP or under mtDNA depletion (Fig. 5d).
Quantitation of morphology, as in Figs. 2c and 3f, supports
this: CCCP-treated HCT116 cells show a dramatic increase
in cells with fragmented mitochondria (98 ± 1%) com-
pared with untreated HCT116s (24 ± 6%). Conversely,
DRP1 knockout cells show overwhelmingly reticular
morphology (96 ± 2%) that does not change in response to
CCCP treatment (97 ± 2%). These results demonstrate
that DRP1 knockout cells are insensitive to loss of Dwm,
and indicate that DRP1 plays a major role in maintaining
Dwm-dependent mitochondrial fission/fusion balance.
DRP1 and OMA1 coordinately impact
mitochondrial fusion and OPA1
Collectively, our findings indicate that both OMA1 and
DRP1 are required for Dwm-dependent mitochondrial
dynamic balance, as cells lacking either factor maintain
mitochondrial interconnection when challenged with loss
of Dwm (Figs. 3, 5). Moreover, WT cells challenged with
CCCP followed by recovery in CCCP-free media show
extensive reticular mitochondria, despite the lack of
abundant L-OPA1 in these cells (Fig. 4). These findings
suggest that OMA1 and DRP1 cooperatively act to mediate
Dwm-dependent mitochondrial fusion/fission balance.
To explore this possibility, we hypothesized that CCCP
challenge and recovery would cause an additive increase in
mitochondrial interconnection even in the presence of a
stable pool of L-OPA1. To test this, we challenged
OMA1-/- cells with CCCP treatment and recovery (in
CCCP-free media) as in Fig. 4. Untreated OMA1-/- cells
showed the expected mixture of reticular and intermediate
morphologies expected, as per Fig. 3. Strikingly, however,
OMA1-/- cells challenged with CCCP and recovery
showed a robust increase in reticular mitochondrial mor-
phology, with elaborately interconnected mitochondria
apparent (Fig. 6a). Quantitation confirmed this: while
28 ± 2% of untreated OMA1-/- cells had a reticular
mitochondrial morphology, OMA1-/- cells given CCCP
challenge and recovery showed a significant increase, with
45 ± 5% of cells showing a reticular mitochondrial mor-
phology. Thus, despite the presence of a stable pool of
available Dwm-independent L-OPA1 (Fig. 3d), OMA1
-/-
cells show an additive increase in mitochondrial intercon-
nection when challenged with CCCP and recovery (Fig. 6a,
b), strongly indicating that DRP1 and OMA1 together
modulate mitochondrial dynamic balance. While OMA1
has been extensively characterized as a key mediator of
Dwm-dependent OPA1 cleavage [32–34], we examined
OPA1 status in DRP1 knockout and control cells to see
whether DRP1 impacts OPA1.
To explore this, we examined HCT116 control and
DRP1 knockout cells via OPA1 Western blotting. Control
HCT116 cells show the expected distribution of OPA1
isoforms, with prominent bands for the b and d isoforms.
Upon incubation with CCCP, HCT116 cells show cleavage
of L-OPA1 isoforms, resulting in accumulation of S-OPA1
isoforms (Fig. 6c), consistent with the mitochondrial
fragmentation found in CCCP-treated HCT116s in Fig. 5d.
Untreated DRP1 knockout cells show the five OPA1 iso-
forms, with comparatively lower L-OPA1 levels than
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control HCT116 cells. Strikingly, however, DRP1 knock-
out cells treated with CCCP show no appreciable change in
OPA1 status: L- and S-OPA1 levels are essentially iden-
tical in control versus CCCP-treated DRP1 knockout cells.
This is consistent with the extensive mitochondrial inter-
connection shown in CCCP-treated DRP1 knockouts
(Fig. 5d, e). While DRP1 knockouts have decreased
L-OPA1 relative to control HCT116s, they do not show
any activation of OPA1 cleavage in response to CCCP
treatment (Fig. 6c). These findings are consistent with loss
of L-OPA1 in response to DRP1 downregulation [56], and
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OPA1
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Fig. 6 Cooperative roles for OMA1 and DRP1 in Dwm-dependent
mitochondrial dynamics. a Untreated and CCCP-treated ? recovery
OMA1-/- cells were incubated with MitoTracker and visualized by
confocal microscopy, n = 3 experiments. b Quantitation of mito-
chondrial morphology of cells in a. Percentage of cells with
predominantly reticular morphology in untreated versus CCCP-
treated ? recovery OMA1-/- cells, n = 3 experiments. *Statistical
significance, p\ 0.01, Student’s t test. c Anti-OPA1 blotting of
control and DRP1 knockout HCT116 cells. Cells were incubated in
the absence or presence of 10 lM CCCP for 1 h and lysates were
prepared, followed by blotting with anti-OPA1. n = 3 experiments.
d Model of Dwm-dependent fission/fusion balance. An intact Dwm (at
or above the 34% TMRE threshold) acts to inhibit both L-OPA1
cleavage by OMA1 and recruitment of DRP1 to mitochondria,
resulting in intact mitochondrial fusion. When Dwm falls below the
observed threshold, fission is activated via increased DRP recruitment
to the mitochondria, while OMA1 proteolytic activity is activated,
rapidly depleting L-OPA1, resulting in a completely fragmented
population of individual organelles
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with OPA1 and the mitochondrial fusion factors to coop-
eratively mediate Dwm-dependent mitochondrial dynamic
balance.
Discussion
The interaction of bioenergetic function with fusion and
fission pathways drives the structure/function dynamics of
mitochondria as an organellar network. While it has been
shown that complete dissipation of Dwm causes mito-
chondrial fragmentation, we here examine (1) the level of
Dwm required, and (2) the contribution of both fission and
fusion pathways, in maintaining Dwm-dependent mito-
chondrial dynamic balance in human cells. Our findings
indicate that a threshold of 34% TMRE-assayed Dwm,
strongly correlating with available fusion-active L-OPA1,
is required to maintain mitochondrial fission/fusion bal-
ance. Surprisingly, cells lacking either OMA1 or DRP1
have obligate mitochondrial fusion and fail to cleave long
OPA1 isoforms in response to pharmacological or genetic
loss of Dwm. These results suggest that OMA1 and DRP1
cooperatively act to mediate mitochondrial Dwm-dependent
dynamic balance, and provide further evidence in support
of a proposed mechanistic link between DRP1-mediated
fission and OPA1 [34, 57]. As mitochondrial dynamic
balance is crucial to cellular processes such as apoptosis,
this ‘tipping point’ mechanism of mitochondrial dynamic
balance will have far-reaching impacts on these key
pathways.
Mitochondrial dynamic balance requires a threshold
of Dwm
Here, we address a key question of mitochondrial struc-
ture/function relationships: to what extent can the
mitochondrial network lose bioenergetic function before
dynamic balance is compromised? While total collapse of
Dwm has been shown to cause fragmentation of the mito-
chondrial network [4, 32, 33], the functional tipping point
of Dwm-dependent mitochondrial dynamics has remained
unknown. Mitochondrial threshold effects have been
extensively documented in mtDNA-derived neuromuscular
diseases: cells or tissues carrying greater than 80–90%
mutant mtDNA typically show collapse of bioenergetic
capacity [30]. Previously, we found that cells carrying a
mutation load greater than 90% D-mtDNA lost the ability
to maintain mitochondrial interconnection [17]. Here, we
explore the functional and mechanistic tipping point behind
this threshold using TMRE flow cytometry to assay Dwm,
and confocal imaging to monitor mitochondrial organiza-
tion. When normalized against the TMRE value of
untreated WT cells as 100%, our data indicate that cells
below 34% TMRE signal have disrupted fission/fusion
homeostasis. CCCP titration demonstrates that at concen-
trations above 4.75 lM, cells have obligate fragmentation
of the mitochondrial network (Fig. 2). This loss of mito-
chondrial interconnection correlates with loss of fusion-
active L-OPA1 isoforms (Fig. 3a, b), strongly indicating
that OPA1-mediated inner membrane fusion per se is lost
beyond this point. These findings demonstrate a key
bioenergetic determinant of mitochondrial fission/fusion
dynamics. Further research may employ alternate methods
such as live-cell imaging [43] and heme oxidation state
[47] to confirm the Dwm threshold in mV. In addition, this
Dwm threshold likely contributes to the canonical mito-
chondrial genetic threshold effect: our model predicts that
any mtDNA mutation that pushes Dwm below this thresh-
old commits the organelle to obligate fission. As such, this
parameter is likely to be of critical importance to mito-
chondrial pathology in a range of human diseases, as well
as therapeutic strategies seeking to eliminate Dwm-im-
pacting mutant mtDNAs through pathways such as
autophagy [58].
OMA1 and DRP1 coordinately mediate Dwm-
dependent mitochondrial dynamics
As mitochondrial fission and fusion pathways have distinct
sets of mediating factors, either pathway (or both) could be
mechanistically responsible for this tipping point threshold.
Mitochondrial fusion has been shown to be dependent on
Dwm [4], mediated by L-OPA1 isoforms [48] that are
cleaved to fusion-inactive S-OPA1 by OMA1 in response
to loss of Dwm [32, 33]. These findings suggested that
fusion is the major mediator of Dwm-dependent mito-
chondrial dynamics, somewhat de-emphasizing the role of
DRP1-mediated fission. However, our results show that
cells lacking either OMA1 or DRP1 are insensitive to loss
of Dwm. If OMA1 alone controlled Dwm-dependent mito-
chondrial dynamics, DRP1 knockout cells would fragment
in q0 or CCCP-treated lines. The highly interconnected
mitochondrial morphology of DRP1 knockout cells (Fig. 4)
despite their lack of abundant L-OPA1 (Fig. 5) demon-
strates the importance of DRP1. Similarly, cells treated
with CCCP, with subsequent recovery in fresh media, do
not show restoration of L-OPA1 (Fig. 4b), but nevertheless
show striking mitochondrial interconnection (Fig. 4a).
Taken together, these data support a strong role for DRP1
and fission per se in maintaining Dwm-dependent mito-
chondrial dynamic balance.
Moreover, our results support both functional coordi-
nation and mechanistic interaction of OPA1-mediated
fusion and DRP1-mediated fission. While experiments in
cells lacking OMA1 (Fig. 3) or DRP1 (Fig. 5) show that
both are necessary for mitochondrial dynamic balance, the
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decreased L-OPA1 observed in DRP1 knockout cells
(Fig. 6c) indicates that DRP1 is necessary to maintain
L-OPA1 stability. This enhanced OPA1 processing is
consistent with Mopert et al. [57], who found similar
results in response to transient knockdown of DRP1, while
Huang et al. found that DRP interacts with mitofusin 2
[59], consistent with DRP1 interactions with the mito-
chondrial fusion machinery. These findings suggest a role
for DRP1 in stabilizing mitochondrial fission/fusion factors
via direct and indirect protein–protein interactions span-
ning the outer and inner mitochondrial membranes.
Thus, while mitochondrial fission and fusion have fre-
quently been discussed as mechanistically distinct
pathways, these results support a model in which an intact
(i.e., above threshold) Dwm provides a check to both
OMA1 and DRP1, allowing a balance of fission and fusion
with both DRP1 and OMA1 interacting (directly or indi-
rectly) with OPA1. Loss of Dwm to levels below the
observed 34% TMRE threshold simultaneously activates
OMA1 cleavage of L-OPA1 and mitochondrial recruitment
of DRP1, collapsing mitochondrial organization to an
obligately fragmented state (Fig. 6d). It is likely that the
loss of Dwm below threshold causes profound changes in
conformation and enzymatic activity of multiple proteins at
the mitochondrial inner and outer membranes, altering the
protein–protein interactions that determine mitochondrial
structural dynamics. OMA1 has been shown to undergo
self-cleavage and activation of L-OPA1 proteolysis during
membrane depolarization [60], while Anand et al. found
that expression of S-OPA1 is sufficient to induce mito-
chondrial fission, with S-OPA1 frequently colocalizing
with DRP1 at ER-mitochondrial sites of contact [34]; the
authors postulated that S-OPA1 may stimulate DRP1 fis-
sion activity. Dwm-dependent DRP1 fission activity is
activated by phosphorylation at S637 [27], and can be
activated by calcineurin in response to increased cytosolic
calcium [53]. Recruitment of DRP1 to mitochondria is
mediated by actin [61, 62]. Taken together, these findings
indicate that Dwm-dependent mitochondrial structural
homeostasis involves the highly dynamic realignment and
recruitment of multiple factors in different mitochondrial
and cellular compartments.
Mitochondrial fission/fusion status directly impacts a
broad range of cellular processes such as apoptosis. Con-
sistent with this, cells below the Dwm threshold show
dramatically decreased viability when challenged with
galactose-containing media (Suppl. Figure 3). As such, this
tipping point threshold of Dwm-dependent fission/fusion
balance may have major impacts on cell-wide signaling
events including autophagy, mitosis, and nutrient utiliza-
tion. For example, collapse of Dwm is a key step in
mitochondrial autophagy [63], causing recruitment of the
Parkin E3 ubiquitin ligase to the mitochondria and
targeting the organelle to the autophagosome [64], while
mitochondrial fission is directly activated by AMP kinase
signaling [65]. These findings thus have direct relevance to
a wide range of prevalent diseases that include mitochon-
drial dysfunction in their pathogenesis. Mitochondrial
dynamics are increasingly found to be critical for ener-
getically dependent tissues such as heart [66] and skeletal
muscle [67], with decreased OxPhos function and disrupted
fission/fusion balance emerging in patient samples and
disease models of neuromuscular diseases [30], neurode-
generative aging and Parkinson’s disease [68, 69], diabetes
[70–72], and heart failure [28]. As such, our findings
illustrate a basic mechanism of mitochondrial struc-
ture/function homeostasis with major implications for the
pathogenesis and translational treatment of these disorders.
Materials and methods
Cell culture
Human 143B osteosarcoma cell lines FLP6a39.2 (WT) and
143B206 (q0) were described previously [16, 19], as have
OMA1?/? and OMA1-/- mouse embryonic fibroblasts
(MEFs) [52] and human colorectal carcinoma HCT116
control and DRP1 knockout cell lines [73]. Cells were
grown in high-glucose Dulbecco’s Modified Eagle’s med-
ium (DMEM) with 10% fetal bovine serum supplemented
with 50 lg/mL uridine in 5% CO2 at 37 C. CCCP and
mdivi-1 (Sigma, St. Louis, MO, USA) were dissolved as
stock solutions in DMSO for dilution in complete media.
All cell culture reagents were from ThermoFisher (Wal-
tham, MA, USA).
Fluorescence microscopy
Cultured cells were seeded to 18 mm2 glass coverslips.
Coverslips were incubated with MitoTracker CMXRos
(Invitrogen Molecular Probes, Carlsbad, CA, USA), fol-
lowed by fixation in 4% paraformaldehyde in PBS. For
immunolabeling of the translocase of the outer mitochon-
drial membrane-20 protein (TOM20), cells were
permeabilized with 0.1% TX-100 in PBS, followed by
blocking in 10% normal goat serum and incubation with
anti-TOM20 monoclonal antibody FL-145 at 1:100 dilution
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Coverslips were incubated with goat anti-mouse Alexa488-
conjugated secondary antibody at 1:100 dilution (Invitro-
gen Molecular Probes, Carlsbad, CA, USA), followed by
staining with diaminophenylindole (DAPI) and mounting
in 50% glycerol in PBS. Coverslips were imaged on an
Olympus Fluoview FV-10i (Olympus, Center Valley, PA,
USA) with a 609 UPLSAP60xW objective with aperture
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1.2 and 39 optical zoom at room temperature. For scoring
of mitochondrial morphology, individual cell profiles on
confocal micrographs were scored as predominantly retic-
ular if they had fewer than three instances of fragmented
mitochondria. Cells were scored as predominantly frag-
mented if they displayed fewer than three instances of
mitochondrial interconnection. All others were scored as
having intermediate mitochondrial morphology.
Flow cytometry
To assay Dwm using flow cytometry, we modified our
previous method using the Dwm-specific dye tetramethyl
rhodamine ester (TMRE) [19]. Briefly, cells were seeded in
100-mm dishes and incubated with 100 nM TMRE for
20 min, followed by trypsinization and two washes in PBS.
Cells were resuspended in 1 mL of PBS and analyzed using
a BD Biosciences LSR Fortessa.
PCR analysis of mtDNA
Total cellular DNA was isolated using proteinase K
digestion, followed by phenol/chloroform extraction and
ethanol precipitation, as previously [16]. Forward primer
ACGCCAAAATCCATTTCACT and reverse primer
CGGGAATTGCATCTGTTTTT amplify nt7130-8113 of
human mtDNA. Reactions were electrophoresed on a 1%
agarose gel and imaged using a Fotodyne Foto/Eclipse gel
documentation system.
Western blot analysis
Cells were lysed using a modified RIPA buffer on ice, and
lysates were run on a 10% SDS-PAGE gel, followed by
transfer to Immobilon PVDF membrane (Bio-Rad, Red-
mond, WA, USA). Anti-OPA1 blotting used separation of
proteins on a 6% SDS-PAGE gel, per Griparic et al. [48].
Membranes were blocked in 5% milk in TBS overnight at 4
degrees C, followed by incubation with anti-MTCO2 mon-
oclonal antibody ab110258 at 1:1000 dilution (Abcam,
Cambridge, MA, USA), anti-DRP1 monoclonal ab56788 at
1:1000 dilution (Abcam, Cambridge,MA,USA), anti-OPA1
monoclonal antibody 612606 at 1:500 dilution (BD Bio-
sciences, San Jose, CA, USA) and goat anti-mouse poly-
HRP secondary antibody at 1:3000 dilution. Blots were
developed using WestDura chemiluminescent reagents and
imaged using a Kodak 4000MM Image Station or Bio-Rad
ChemiDoc XRS. Anti-a-tubulin monoclonal antibody
(Sigma) was employed as a loading control.
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